Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 18, 2022
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
[ Mon, Apr 18th 2022
] - WOPRAI
Sun, April 17, 2022
[ Sun, Apr 17th 2022
] - WOPRAI
[ Sun, Apr 17th 2022
] - WOPRAI
Thu, April 14, 2022
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
[ Thu, Apr 14th 2022
] - WOPRAI
Elemer Piros Downgraded (APLS) to Strong Sell and Held Target at $40 on, Apr 14th, 2022
Elemer Piros of Roth Capital, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Strong Sell and Held Target at $40 on, Apr 14th, 2022.
Elemer has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Elemer's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Elemer
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
- Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022
